Sign inGet started

Ferra Joseph J Jr

Insider CIK 1733790 · SYRS Chief Financial Officer · ELEV INTERIM CEO & CFO, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ELEV Elevation Oncology, Inc. M Exercise deriv2025-06-162025-06-1812,560— $00SEC↗
ELEV Elevation Oncology, Inc. M Exercise2025-06-162025-06-1812,560— $0149,712SEC↗
ELEV Elevation Oncology, Inc. F Tax w/h2025-06-162025-06-184,627$0.39 $1.8K145,085SEC↗
ELEV Elevation Oncology, Inc. M Exercise deriv2025-05-152025-05-196,250— $068,750SEC↗
ELEV Elevation Oncology, Inc. M Exercise2025-05-152025-05-196,250— $0139,455SEC↗
ELEV Elevation Oncology, Inc. F Tax w/h2025-05-152025-05-192,303$0.30 $691137,152SEC↗
ELEV Elevation Oncology, Inc. M Exercise deriv2025-03-162025-03-1812,562— $012,560SEC↗
ELEV Elevation Oncology, Inc. F Tax w/h2025-03-162025-03-184,628$0.53 $2.5K133,205SEC↗
ELEV Elevation Oncology, Inc. M Exercise2025-03-162025-03-1812,562— $0137,833SEC↗
ELEV Elevation Oncology, Inc. M Exercise deriv2025-02-152025-02-1925,000— $075,000SEC↗
ELEV Elevation Oncology, Inc. A Award deriv2025-02-152025-02-19800,000— $0800,000SEC↗
ELEV Elevation Oncology, Inc. F Tax w/h2025-02-152025-02-199,211$0.67 $6.2K125,271SEC↗
ELEV Elevation Oncology, Inc. M Exercise2025-02-152025-02-1925,000— $0134,482SEC↗
ELEV Elevation Oncology, Inc. M Exercise deriv2024-12-162024-12-1812,563— $025,122SEC↗
ELEV Elevation Oncology, Inc. F Tax w/h2024-12-162024-12-184,629$0.64 $3.0K109,482SEC↗
ELEV Elevation Oncology, Inc. M Exercise2024-12-162024-12-1812,563— $0114,111SEC↗
ELEV Elevation Oncology, Inc. M Exercise deriv2024-09-162024-09-1812,562— $037,685SEC↗
ELEV Elevation Oncology, Inc. M Exercise2024-09-162024-09-1812,562— $0106,176SEC↗
ELEV Elevation Oncology, Inc. F Tax w/h2024-09-162024-09-184,628$0.61 $2.8K101,548SEC↗
ELEV Elevation Oncology, Inc. M Exercise deriv2024-06-162024-06-1812,562— $050,247SEC↗
ELEV Elevation Oncology, Inc. F Tax w/h2024-06-162024-06-184,628$3.23 $14.9K93,614SEC↗
ELEV Elevation Oncology, Inc. M Exercise2024-06-162024-06-1812,562— $098,242SEC↗
ELEV Elevation Oncology, Inc. M Exercise deriv2024-03-162024-03-1912,562— $062,809SEC↗
ELEV Elevation Oncology, Inc. F Tax w/h2024-03-162024-03-194,773$4.39 $21.0K85,680SEC↗
ELEV Elevation Oncology, Inc. M Exercise2024-03-162024-03-1912,562— $090,453SEC↗
ELEV Elevation Oncology, Inc. A Award deriv2024-02-152024-02-20600,000— $0600,000SEC↗
ELEV Elevation Oncology, Inc. A Award deriv2024-02-152024-02-20100,000— $0100,000SEC↗
ELEV Elevation Oncology, Inc. M Exercise deriv2023-12-162023-12-1912,563— $075,371SEC↗
ELEV Elevation Oncology, Inc. F Tax w/h2023-12-162023-12-194,773$0.51 $2.4K77,891SEC↗
ELEV Elevation Oncology, Inc. M Exercise2023-12-162023-12-1912,563— $082,664SEC↗
ELEV Elevation Oncology, Inc. M Exercise deriv2023-09-162023-09-1912,562— $087,934SEC↗
ELEV Elevation Oncology, Inc. M Exercise2023-09-162023-09-1912,562— $074,874SEC↗
ELEV Elevation Oncology, Inc. F Tax w/h2023-09-162023-09-194,773$0.73 $3.5K70,101SEC↗
ELEV Elevation Oncology, Inc. A Award deriv2023-07-122023-07-1435,000— $035,000SEC↗
ELEV Elevation Oncology, Inc. M Exercise deriv2023-06-162023-06-2112,563— $0100,496SEC↗
ELEV Elevation Oncology, Inc. F Tax w/h2023-06-162023-06-214,773$1.47 $7.0K62,312SEC↗
ELEV Elevation Oncology, Inc. M Exercise2023-06-162023-06-2112,563— $067,085SEC↗
ELEV Elevation Oncology, Inc. M Exercise deriv2023-03-162023-03-2012,563— $0113,059SEC↗
ELEV Elevation Oncology, Inc. M Exercise2023-03-162023-03-2012,563— $059,295SEC↗
ELEV Elevation Oncology, Inc. F Tax w/h2023-03-162023-03-204,773$2.35 $11.2K54,522SEC↗
ELEV Elevation Oncology, Inc. A Award deriv2023-02-152023-02-17270,000— $0270,000SEC↗
ELEV Elevation Oncology, Inc. A Award deriv2023-01-062023-01-10240,000— $0240,000SEC↗
ELEV Elevation Oncology, Inc. A Award deriv2023-01-062023-01-1030,000— $030,000SEC↗
ELEV Elevation Oncology, Inc. M Exercise deriv2022-12-162022-12-1912,562— $0125,622SEC↗
ELEV Elevation Oncology, Inc. M Exercise2022-12-162022-12-1912,562— $051,505SEC↗
ELEV Elevation Oncology, Inc. F Tax w/h2022-12-162022-12-194,773$0.95 $4.5K46,732SEC↗
ELEV Elevation Oncology, Inc. M Exercise deriv2022-09-162022-12-1912,562— $0138,184SEC↗
ELEV Elevation Oncology, Inc. M Exercise2022-09-162022-12-1912,562— $043,716SEC↗
ELEV Elevation Oncology, Inc. F Tax w/h2022-09-162022-12-194,773$1.25 $6.0K38,943SEC↗
ELEV Elevation Oncology, Inc. M Exercise deriv2022-06-162022-12-1950,249— $0150,746SEC↗
ELEV Elevation Oncology, Inc. M Exercise2022-06-162022-12-1950,249— $050,249SEC↗
ELEV Elevation Oncology, Inc. F Tax w/h2022-06-162022-12-1919,095$1.26 $24.1K31,154SEC↗
ELEV Elevation Oncology, Inc. A Award deriv2022-02-142022-02-1660,000— $060,000SEC↗
ELEV Elevation Oncology, Inc. A Award deriv2021-06-242021-06-28200,995— $0200,995SEC↗
ELEV Elevation Oncology, Inc. A Award deriv2021-06-242021-06-28249,104— $0249,104SEC↗
SYRS Syros Pharmaceuticals, Inc A Award deriv2021-02-172021-02-19119,000— $0119,000SEC↗
SYRS Syros Pharmaceuticals, Inc A Award deriv2020-02-132020-02-1494,000— $094,000SEC↗
SYRS Syros Pharmaceuticals, Inc A Award deriv2019-02-122019-02-1475,000— $075,000SEC↗
SYRS Syros Pharmaceuticals, Inc A Award2019-02-122019-02-1487,000— $087,000SEC↗
SYRS Syros Pharmaceuticals, Inc A Award deriv2018-03-122018-03-1250,000— $050,000SEC↗
SYRS Syros Pharmaceuticals, Inc A Award deriv2018-03-122018-03-12150,000— $0150,000SEC↗